A1 Refereed original research article in a scientific journal

5 ',5 '-Phosphodiesters and esterase labile triesters of 2 '-C-methylribonucleosides




AuthorsLeisvuori A, Ahmed Z, Ora M, Blatt L, Beigelman L, Lonnberg H

PublisherARKAT USA INC

Publication year2012

JournalArkivoc

Journal name in sourceARKIVOC

Journal acronymARKIVOC

Issue5

First page 226

Last page243

Number of pages18

ISSN1551-7004

DOIhttps://doi.org/10.3998/ark.5550190.0013.520

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/3182820


Abstract
Bis(2'-C-methyladenosin-5'-yl) (11), bis(2'-C-methylguanosin-5'-yl) (13), bis(2'-C-methyluridin-5'-yl) (15) and 2'-C-methylguanosin-5'-yl 2'-C-methyluridin-5'-yl (16) phosphodiesters have been prepared as pro-drug candidates for the respective 2'-C-methylribonucleoside 5'-monophosphates, expectedly exhibiting antiviral activity against Hepatitis C virus. Additionally, the bis(2'-C-methyladenosine) diester has been converted to 3-acetyloxymethoxy-2,2-bis(ethoxycarbonyl)propyl (19) or pivaloyloxymethyl (20) triester. The underlying idea is that the 5',5'-phosphodiester is first released by intracellular carboxyesterases and subsequently cleaved to nucleoside and nucleoside 5'-monophosphate by phosphodiesterases.


Research Areas


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 18:09